Education
About Us
Working with TipRanks
Follow Us
Zhaoke Ophthalmology Ltd. (HK:6622)
:6622
Total Valuation
Zhaoke Ophthalmology Ltd. has a market cap or net worth of HK$1.99B. The enterprise value is HK$185.56M.
Market CapHK$1.99B
Enterprise ValueHK$185.56M
Share Statistics
Zhaoke Ophthalmology Ltd. has 547,955,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding547,955,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhaoke Ophthalmology Ltd.’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -10.59%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-10.59%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee235.80K
Profits Per Employee-807.80K
Employee Count294
Asset Turnover0.03
Inventory Turnover1.18
Valuation Ratios
The current PE Ratio of Zhaoke Ophthalmology Ltd. is ―. Zhaoke Ophthalmology Ltd.’s PEG ratio is 0.07.
PE Ratio―
PS Ratio8.88
PB Ratio0.32
Price to Fair Value0.32
Price to FCF-2.07
Price to Operating Cash Flow-17.98
PEG Ratio0.07
Income Statement
In the last 12 months, Zhaoke Ophthalmology Ltd. had revenue of 69.32M and earned -237.49M in profits. Earnings per share was -0.43.
Revenue69.32M
Gross Profit51.80M
Operating Income-227.99M
Pretax Income-237.49M
Net Income-237.49M
EBITDA-251.23M
Earnings Per Share (EPS)-0.43
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Zhaoke Ophthalmology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.35
52-Week Price Change132.67%
50-Day Moving Average3.78
200-Day Moving Average2.45
Relative Strength Index (RSI)39.81
Average Volume (3m)1.70M
Important Dates
Zhaoke Ophthalmology Ltd. upcoming earnings date is Mar 30, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 30, 2026
Ex-Dividend Date―
Financial Position
Zhaoke Ophthalmology Ltd. as a current ratio of 5.16, with Debt / Equity ratio of 15.91%
Current Ratio5.16
Quick Ratio5.11
Debt to Market Cap0.35
Net Debt to EBITDA3.51
Interest Coverage Ratio-23.99
Taxes
In the past 12 months, Zhaoke Ophthalmology Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zhaoke Ophthalmology Ltd. EV to EBITDA ratio is 1.06, with an EV/FCF ratio of 0.90.
EV to Sales-3.85
EV to EBITDA1.06
EV to Free Cash Flow0.90
EV to Operating Cash Flow1.05
Balance Sheet
Zhaoke Ophthalmology Ltd. has HK$1.05B in cash and marketable securities with HK$271.40M in debt, giving a net cash position of HK$782.82M billion.
Cash & Marketable SecuritiesHK$1.05B
Total DebtHK$271.40M
Net CashHK$782.82M
Net Cash Per ShareHK$1.43
Tangible Book Value Per ShareHK$2.72
Margins
Gross margin is 49.28%, with operating margin of -328.88%, and net profit margin of -342.58%.
Gross Margin49.28%
Operating Margin-328.88%
Pretax Margin-342.58%
Net Profit Margin-342.58%
EBITDA Margin-362.40%
EBIT Margin-410.98%
Analyst Forecast
The average price target for Zhaoke Ophthalmology Ltd. is HK$3.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$3.50
Price Target Upside0.29% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-38.38%
EPS Growth Forecast-22.12%